Close Menu

NEW YORK (GenomeWeb) – Helping clinicians effectively respond to the threat of sepsis sits at the core of BioMérieux's strategy to provide effective diagnostic tools and tests for infectious diseases, as was evident by comments and presentations given by the company's executives earlier this month at the American Association for Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo in Philadelphia.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.